| 产品名称 | Peptides EP08035_1 | HIV-1 RT 476-484 (HLA-A*02:01) |
|---|---|
| 目录号 | EP08035_1 |
| 别名 | HIV-1 RT 476-484 (HLA-A*02:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP08035_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP08035_1 | HIV-1 RT 476-484 (HLA-A*02:01)
品名:HIV-1 RT 476-484 (HLA-A*02:01)
货号:EP08035_1
规格:1 mg; 5 mg
品牌:Peptides.de
产品描述
ILKEPVHGV is a linear peptidic epitope studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1. HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele. This is a reverse transcriptase (RT) epitope (Pol residues 476-484). Within HIV-1 RT the peptide appears to be the dominant HLA A*0201-restricted epitope. Was used to investigate possible mechanisms behind HIV-1 escape from CTL. IV9 is the actual epitope processed and presented in HIV-1-infected cell lines.
| Protein | Gag-Pol polyprotein |
| Species | Human immunodeficiency virus 1 (HIV-1) |
| Application | Flow Cytometry |
| Indication | Infectious disease |